共 50 条
- [31] Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxylethy]-1,3-dimethyl-piperazin-2-one (AZD5153)JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (17) : 7801 - 7817Bradbury, Robert H.Callis, RowenaCarr, Gregory R.Chen, HuaweiClark, EdwinFeron, LymanGlossop, SteveGraham, Mark A.Hattersley, MaureenJones, ChrisLamont, Scott G.Ouvry, GillesPatel, AnilPatel, JoeRabow, Alfred A.Roberts, Craig A.Stokes, StephenStratton, NatalieWalker, Graeme E.Ward, LaraWhalley, DavidWhittaker, DavidWrigley, GailWaring, Michael J.
- [32] Discovery and Biological Characterization of (2R,4S)-1′-Acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4′-bipiperidine-1-carboxamide as a New Potent and Selective Neurokinin 1 (NK1) Receptor Antagonist Clinical CandidateJOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (04) : 1071 - 1079Di Fabio, RomanoAlvaro, GiuseppeGriffante, CristianaPizzi, Domenica A.Donati, DanieleMattioli, MarioCimarosti, ZadeoGuercio, GiuseppeMarchioro, CarlaProvera, StefanoZonzini, LauraMontanari, DinoMelotto, SergioGerrard, Philip A.Trist, David G.Ratti, EmiliangeloCorsi, Mauro
- [33] Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidateBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5313 - 5319Anselm, LilliBanner, David W.Benz, JoergZbinden, Katrin GroebkeHimber, JacquesHilpert, HansHuber, WalterKuhn, BerndMary, Jean-LucOtteneder, Michael B.Panday, NarendraRicklin, FabienneStahl, MartinThomi, StefanHaap, Wolfgang
- [34] Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent AnalgesicJOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 9458 - 9483Huang, HuomingLi, XuepingXie, PengLi, XinweiXu, XueJunQian, YuanyuanYuan, CongminMeng, XiangguoChai, JingRuiChen, JingLiu, JingWang, WenliLi, WeiWang, YuJunFu, WeiLiu, Jinggen
- [35] Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor AntagonistJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (03): : 622 - 635Villetti, G.Pastore, F.Bergamaschi, M.Bassani, F.Bolzoni, P. T.Battipaglia, L.Amari, G.Rizzi, A.Delcanale, M.Volta, R.Cenacchi, V.Cacciani, F.Zaniboni, M.Berti, F.Rossoni, G.Harrison, S.Petrillo, P.Santoro, E.Scudellaro, R.Mannini, F.Geppetti, P. A.Razzetti, R.Patacchini, R.Civelli, M.
- [36] Discovery Process and Pharmacological Characterization of 2-(S)-(4-Fluoro-2-methylphenyl)piperazine-1-carboxylic Acid [1-(R)-(3,5-Bis-trifluoromethylphenyl)ethyl]methylamide (Vestipitant) as a Potent, Selective, and Orally Active NK1 Receptor AntagonistJOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (10) : 3238 - 3247Di Fabio, RomanoGriffante, CristianaAlvaro, GiuseppePentassuglia, GiorgioPizzi, Domenica A.Donati, DanieleRossi, TinoGuercio, GiuseppeMattioli, MarioCimarosti, ZadeoMarchioro, CarlaProvera, StefanoZonzini, LauraMontanari, DinoMelotto, SergioGerrard, Philip A.Trist, David G.Ratti, EmiliangetoCorsi, Mauro
- [37] N-[(1-BUTYL-4-PIPERIDINYL)METHYL]-3,4-DIHYDRO-2H-[1,3]OXAZINO[3,2-A]INDOLE-10-CARBOXAMIDE HYDROCHLORIDE - THE FIRST POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST AMIDE WITH ORAL ACTIVITYJOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (24) : 4760 - 4763GASTER, LMJOINER, GFKING, FDWYMAN, PASUTTON, JMBINGHAM, SELLIS, ESSANGER, GJWARDLE, KA
- [38] The discovery of (1R, 3R)-1-(3-chloro-5-fluorophenyl)-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonitrile, a potent and selective agonist of human transient receptor potential cation channel subfamily m member 5 (TRPM5) and evaluation of as a potential gastrointestinal prokinetic agentBIOORGANIC & MEDICINAL CHEMISTRY, 2022, 76Sabat, M.Raveglia, L. F.Aldegheri, L.Barilli, A.Bianchi, F.Brault, L.Brodbeck, D.Feriani, A.Lingard, I.Miura, J.Myers, R.Piccoli, L.Tassini, S.Tyhonas, J.Ton-Nu, T.Wang, H.Virginio, C.
- [39] Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 794 - 806Sturino, Claudio F.O'Neill, GaryLachance, NicolasBoyd, MichaelBerthelette, CarlLabelle, MarcLi, LianhaiRoy, BrunoScheigetz, JohnTsou, NancyAubin, YvesBateman, Kevin P.Chauret, NathalieDay, Stephen H.Levesque, Jean-FrancoisSeto, CarmaiSilva, Jose H.Trimble, Laird A.Carriere, Marie-ClaudeDenis, DanielleGreig, GillianKargman, StaciaLamontagne, SoniaMathieu, Marie-ClaudeSawyer, NicoleSlipetz, DeborahAbraham, William M.Jones, TomMcAuliffe, MaliaPiechuta, HanaNicoll-Griffith, Deborah A.Wang, ZhaoyinZamboni, RobertYoung, Robert N.Metters, Kathleen M.
- [40] 2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: A Potent Human NK1 Receptor Antagonist with Multiple Clearance PathwaysJOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5940 - 5948Kassick, Andrew J.Jiang, JinlongBunda, JaimeWilson, DavidBao, JianmingLu, HuagangLin, PeterBall, Richard G.Doss, George A.Tong, XinchunTsao, Kwei-Lan C.Wang, HongChicchi, GaryKaranam, BindhuTschirret-Guth, RichardSamuel, KopparaHora, Donald F.Kumar, SanjeevMadeira, MariaEng, WaisiHargreaves, RichardPurcell, MonaGantert, LizaCook, JacquelynDeVita, Robert J.Mills, Sander G.